2009: 101/1 (Jan) pp. 1-216

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

36 articles
1.
Face to face with basic and clinical research in Thrombosis and Haemostasis

Klaus T. Preissner1, Gregory Y. H. Lip2

1Institute for Biochemistry, Medical School, Justus Liebig University, Giessen, Germany; 2Haemostasis Thrombosis & Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

Thrombosis and Haemostasis 2009 101 1: 1-1

http://dx.doi.org/10.1160/TH08-12-0791

[Summary] [Free download]
2.
Dabigatran etexilate for prevention of venous thromboembolism

John E. Eikelboom1; Jeffrey I. Weitz1,2

1Department of Medicine, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada; 2Department of Biochemistry and Medical Sciences, McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2009 101 1: 2-4

http://dx.doi.org/10.1160/TH08-10-0708

[Summary] [Free download]
3.
VTE recurrence in patients with inherited deficiencies of natural anticoagulants

Francesco Dentali1; Monica Gianni2

1Department of Cinical Medicine, Insubria University, Varese, Italy; 2Department of Cardiology, Hospital of Tradate, Tradate, Italy

Thrombosis and Haemostasis 2009 101 1: 5-6

http://dx.doi.org/10.1160/TH08-11-0763

[Summary] [Free download]
4.
Pulmonary embolism diagnosis: Remember the history and physical exam

Samuel Z. Goldhaber

Cardiovascular Division, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 101 1: 7-8

http://dx.doi.org/10.1160/TH08-10-0700

[Summary] [Free download]
5.
Drug-eluting balloons for percutaneous coronary interventions

Marco Zimarino; Raffaele De Caterina

Institute of Cardiology and Center of Excellence on Aging, “G. d’Annunzio” University, Chieti, Italy

Thrombosis and Haemostasis 2009 101 1: 9-11

http://dx.doi.org/10.1160/TH08-11-0770

[Summary] [Free download]
6.
Another view on prasugrel

Andreas Calatzis

Haemostasis and Transfusion Medicine Department, University Hospital, Ludwig Maximillians University, Munich, Germany

Thrombosis and Haemostasis 2009 101 1: 12-13

http://dx.doi.org/10.1160/TH08-11-0745

[Summary] [Free download]
7.
[Add to basket]
Prasugrel development − Claims and achievements

Victor Serebruany; Inna Shalito; Olga Kopyleva

HeartDrug™ Research Laboratories, Johns Hopkins University, Towson, Maryland, USA

Thrombosis and Haemostasis 2009 101 1: 14-22

http://dx.doi.org/10.1160/TH08-07-0452

[Summary] [PDF] [Pay per view]
8.
[Add to basket]
Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting

Alex Hobson1; Nick Curzen1,2

1Wessex Cardiac Unit, Southampton University Hospitals NHS Trust, Southampton, UK; 2Southampton University Medical School, Southampton, UK

Thrombosis and Haemostasis 2009 101 1: 23-30

http://dx.doi.org/10.1160/TH08-06-0417

[Summary] [PDF] [Pay per view]
9.
[Add to basket]
The 8th American College of Chest Physicians Guidelines – A perspective on venous thromboembolism guidelines

Alessandro Squizzato; Walter Ageno

Department of Clinical Medicine, University of Insubria, Varese, Italy

Thrombosis and Haemostasis 2009 101 1: 31-35

http://dx.doi.org/10.1160/TH08-08-0519

[Summary] [PDF] [Pay per view]
10.
Compensatory anti-inflammatory response syndrome

Minou Adib-Conquy; Jean-Marc Cavaillon

Unit Cytokines & Inflammation, Institut Pasteur, Paris, France

Thrombosis and Haemostasis 2009 101 1: 36-47

http://dx.doi.org/10.1160/TH08-07-0421

[Summary] [Free download]
11.
Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease

Rob Hurks1,2; Wouter Peeters1–3; Wouter J. M. Derksen1; Willem E. Hellings1,2; Imo E. Hoefer1; Frans L. Moll2; Dominique P. V. de Kleijn1,3; Gerard Pasterkamp1

1Experimental Cardiology Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands; 2Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands; 3Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands

Thrombosis and Haemostasis 2009 101 1: 48-54

http://dx.doi.org/10.1160/TH08-07-0488

[Summary] [Free download]
12.
[Add to basket]
Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C

Subramanian Yegneswaran; Phuong M. Nguyen; Andrew J. Gale; John H. Griffin

Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, USA

Thrombosis and Haemostasis 2009 101 1: 55-61

http://dx.doi.org/10.1160/TH08-07-0491

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Polymorphisms in the protein C gene as risk factor for venous thrombosis

Elisabeth R. Pomp1; Carine J. M. Doggen1; Hans L. Vos2,3; Pieter H. Reitsma2,3; Frits R. Rosendaal1–3

1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; 2Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands; 3Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

Thrombosis and Haemostasis 2009 101 1: 62-67

http://dx.doi.org/10.1160/TH08-08-0502

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)

Alexander G. G. Turpie1; Kenneth A. Bauer2; Bruce L. Davidson3; William D. Fisher4; Michael Gent1; Michael H. Huo5; Uma Sinha6; Daniel D. Gretler6; for the EXPERT Study Group*

1McMaster University, Hamilton, Ontario, Canada; 2Beth Israel Deaconess Medical Center, Boston, Massachussetts, USA; 3Weill Cornell Medical College, Doha, Qatar; 4McGill University Health Centre, Montreal, Quebec, Canada; 5University of Texas Southwestern Medical Center, Dallas, Texas, USA; 6Portola Pharmaceuticals, Inc., South San Francisco, California, USA

Thrombosis and Haemostasis 2009 101 1: 68-76

http://dx.doi.org/10.1160/TH08-07-0460

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty - A meta-analysis

Sorrel E. Wolowacz1; Neil S. Roskell1; Jonathan M. Plumb2; Joseph A. Caprini3; Bengt I. Eriksson4

1RTI Health Solutions, Williams House, Manchester University Science Park, Lloyd Street North, Manchester, UK; 2Boehringer Ingelheim GmbH, Binger Strasse, Ingelheim am Rhein, Germany; 3Robert R. McCormick School of Engineering and Applied Sciences, Department of Surgery, Evanston Northwestern Healthcare, Evanston IL and Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; 4Professor of Orthopaedics, Surgical Sciences Gothenburg University, Sahlgrenska University Hospital/ÖSTRA, Gothenburg, Sweden

Thrombosis and Haemostasis 2009 101 1: 77-85

http://dx.doi.org/10.1160/TH08-07-0493

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Evaluation of enoxaparin dosing requirements in infants and children - Better dosing to achieve therapeutic levels

Mary E. Bauman1; Mark J. Belletrutti1; Laszlo Bajzar2; Karina L. Black1; Stefan Kuhle3; Michelle L. Bauman2; M. Patricia Massicotte1

1Stollery Children’s Hospital, University of Alberta, Edmonton, Alberta, Canada; 2University of Alberta, Edmonton, Alberta, Canada; 3School of Public Health, University of Alberta, Edmonton, Alberta, Canada

Thrombosis and Haemostasis 2009 101 1: 86-92

http://dx.doi.org/10.1160/TH08-03-0148

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin

Jan-Leendert P. Brouwer1; Willem M. Lijfering1; Min Ki ten Kate1; Hanneke C. Kluin-Nelemans1; Nic J. G. M. Veeger2; Jan van der Meer1

1Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands; 2Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands

Thrombosis and Haemostasis 2009 101 1: 93-99

http://dx.doi.org/10.1160/TH08-06-0364

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort

Carolyn Neville*,1; Joyce Rauch*,2; Jeannine Kassis3; Susan Solymoss4; Lawrence Joseph1,5; Patrick Belisle1; Jerrold S. Levine6; Paul R. Fortin7,8

1Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada; 2Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada; 3Department of Hematology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada; 4Division of Hematology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada; 5Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada; 6Section of Nephrology, Department of Medicine, University of Illinois at Chicago, and Section of Nephrology, Department of Medicine, Jesse Brown Veterans Administration Medical Center, Chicago, Illinois, USA; 7Division of Health Care and Outcome Research, Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada; 8Division of Rheumatology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada

Thrombosis and Haemostasis 2009 101 1: 100-107

http://dx.doi.org/10.1160/TH08-06-0384

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Clopidogrel versus prasugrel in rabbits - Effects on thrombosis, haemostasis, platelet function and response variability

Pancras C. Wong; Earl J. Crain; Carol A. Watson; Ji Hua; William A. Schumacher; Robert Rehfuss

Thrombosis Research, Bristol-Myers Squibb Company, Pennington, New Jersey, USA

Thrombosis and Haemostasis 2009 101 1: 108-115

http://dx.doi.org/10.1160/TH08-07-0456

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Functional variability of platelet response to clopidogrel correlates with P2Y12 receptor occupancy

Claire Bal dit Sollier1; Natacha Berge1; Bernadette Boval2; Lionel Hovsepian3; Ludovic Drouet2

1IVS, Hôpital Lariboisière, Paris, France; 2Haematology Laboratory, Hôpital Lariboisière, Paris, France; 3SGS-ASTER, Paris, France

Thrombosis and Haemostasis 2009 101 1: 116-122

http://dx.doi.org/10.1160/TH08-07-0481

[Summary] [PDF] [Pay per view]
  1-20 21-36
Next page

Articles

You've 682 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...